SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OSI Pharmaceuticals (OSIP) - formerly Oncogene
An SI Board Since December 1997
Posts SubjectMarks Bans Symbol
447 40 0 OSIP
Emcee:  James Reynolds Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
222Mewrrill Lynch's Ende on Tarceva: Message 20206348RCMac-6/9/2004
221Why ASCO presentation slides for Tarceva are not available on CC webcast? IntraMiljenko Zuanic-6/9/2004
220WOW, 50% was SECOND LINE treatment. No wander they have ITT survival benefit. WhMiljenko Zuanic-6/5/2004
219What a recovery today. I imagine there will be a runup to the meeting then a spitechtonicbull-5/28/2004
218Experimental Drug Tarceva Extends Lung-Cancer Survival Not a Cure, But TreatmenDoc Bones-4/27/2004
217,,,,,,,I can now smoke as many Artuo Fuentes as i like. LOL go OSIPM0NEYMADE-4/27/2004
216Congratulation to all longs. :) Unfortunately for me, I was wrong on Tarceva anMiljenko Zuanic-4/26/2004
215>>What about LGND<< LGND's oncology products have completely dituck-4/26/2004
214What about LGNDSPSEIFERT-4/26/2004
21308:09 OSIP OSI Pharma Secondary Plays (38.14 ) -- Update -- Look for sharesDoc Bones-4/26/2004
212Phase III study of Tarceva in NSCLC met its primary endpoint biz.yahoo.comfred hayes-4/26/2004
211<i>The results showed cells which were made resistant to the EGFR MAb stilscaram(o)uche-4/1/2004
210Over 20,000 new cases of prostate are reported in the UK annually. Hormonally banigel bates-1/13/2004
209Phase III Trials of Tarceva Plus Chemotherapy in First-Line Non-Small Cell Lung nigel bates-10/1/2003
208Goddard: The 10-Q is out. There is no mention of Solvay. Why? Is not initiatscaram(o)uche-8/13/2003
207Goddard: Where is the "dabetes (includes the GPCR program) spinout"??scaram(o)uche-8/3/2003
206Goddard: Message 19100109 1. So?? Where is the diabetes/GPCR-asthma spinout?scaram(o)uche-7/10/2003
205So this was what ML was alerting as. Down the road... Press Release Source: GenMiljenko Zuanic-5/8/2003
204Thanks Stafan. Iressa trial was regardless HER1 assay and positive tumor. ZenecMiljenko Zuanic-4/10/2003
203concerning egfr antagonists in the ESGO yesterday one speaker said the followindalroi-4/10/2003
202First, let me say that I'm no fan of Goddard. However!!.... the Genentechscaram(o)uche-4/10/2003
201Bad Day for Genentech: Tarceva and Avastin Doubtful Gregory Frykman, M.D. Genenmopgcw-4/10/2003
200>>8:10AM OSI Pharm: Lehman sees significant Tarceva trial risk (OSIP) 15.8tuck-4/10/2003
199fwiw - Probably got this wrong but sometimes referred to as OSI-774 -or- TarcevJohn McCarthy-12/25/2002
198>>Why both compound skipped PII combination trials???<< Good questifred hayes-12/25/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News